@FierceMedDev: Covidien's CFO exercised his stock options near the company's 52 week high. Story | Follow @FierceMedDev
@MarkHFierce: Intuitive Surgical's latest da Vinci surgical robot could help it rebound from a challenging year. More | Follow @MarkHFierce
@MichaelGFierce: Wearable data-storing 'electronic skin' could deliver drugs for epilepsy, Parkinson's. Item | Follow @MichaelGFierce
@EmilyWFierce: New paper from researchers at Harvard sheds light on PMA supplement applications for medical devices. Article | Follow @EmilyWFierce
> Bausch + Lomb won the FDA's 510(k) clearance for its new laser surgical system. Story
> Stents covered with a biodegradable coating are statistically comparable to everolimus covered stents (which use a durable polymer coating) at two years, according to a new study. Release
> Rotation Medical gained FDA clearance for implantable collagen scaffold technology designed to treat rotator cuff disease. Release
> Japanese regulators are hoping to speed up the medical device registration process. Blog
Biotech News
@FierceBiotech: Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy. More | Follow @FierceBiotech
@JohnCFierce: Celgene doubles down on Forma with a $600M discovery deal tied to a buyout option. Article | Follow @JohnCFierce
@DamianFierce: On the way home from ACC14? Catch up on the state of the PCSK9 race with our in-depth feature. Read | Follow @DamianFierce
@EmilyMFierce: Committee finds 'scientific misconduct' in blockbuster stem cell papers. News | Follow @EmilyMFierce
> Foresite banks $300M to bet on late-stage biotechs. More
> Cubist's superbug drug clears FDA panel, lines up for Pfizer showdown. Piece
Pharma News
@FiercePharma: Gilead's Sovaldi triumph puts major hurt on payers' bottom lines. Story | Follow @FiercePharma
@TracyStaton: RT: Today is the first time in my 10 year data that larger cap biotech is trading at the same PE as US pharma. via @MarkSchoenebaum | Follow @TracyStaton
@EricPFierce: GSK attacks African market with combo of goodwill, R&D and plant projects. More | Follow @EricPFierce
@CarlyHFierce: Donald Trump's Twitter tirade blames vaccines for autism increase. News | Follow @CarlyHFierce
> GSK ditches ovarian cancer plans for Votrient. Article
> It's a big win for Eli Lilly in multibillion-dollar Alimta patent fight. Story
> Actavis shells out $100M for Thai generics maker in bid for Southeast Asia growth. More
Biotech Research News
> Committee finds 'scientific misconduct' in blockbuster stem cell papers. News
> Anticancer compound could reverse symptoms of schizophrenia. More
> New molecule could provide relief for autoimmune, inflammatory diseases. Story
> Report: U.S. can do more to support global health R&D. Coverage
> Antioxidant could slow progression of Lou Gehrig's disease, extend lifespan. Article
> NIH opens largest U.S. neuroscience research center. Item
Pharma Manufacturing News
> Bayer will spend $138M to expand its Beijing plant. Story
> GSK sells Indonesia plant even as it boosts commitment there. Article
> Hospira settles investor suit tied to its manufacturing mess-ups. News
> GSK commits $165M toward 5 more plants in Africa. More
> FDA lets Fresenius import saline to help with shortage. Piece
> Regeneron resolves objections to its new Ireland plant. Item
